跳至主要内容
临床试验/NCT04241341
NCT04241341进行中(未招募)3 期

A Randomized Controlled Trial: Does Immediate Lymphatic Reconstruction Decrease the Incidence of Lymphedema After Axillary Lymph Node Dissection

Memorial Sloan Kettering Cancer Center14 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2020年1月22日最近更新:
适应症

试验速览

阶段
3 期
状态
进行中(未招募)
入组人数
180
试验地点
14
主要终点
the number of patients that had a decrease incidence of lymphedema

研究概览

简要总结

The researchers are doing this study to see if having immediate lymphatic reconstruction after axillary lymph node dissection (ALND) can decrease the development of lymphedema, a side effect of ALND. Other purposes of the study include:

Comparing the approach of immediate lymphatic reconstruction after ALND with the approach of ALND alone Looking at whether having immediate lymphatic reconstruction after ALND improves a person's quality of life Seeing if adding standard of care radiation therapy to either study approach (immediate lymphatic reconstruction after ALND or ALND alone) has an effect on development of lymphedema

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Female breast cancer patients 18-75 years of age
  • Patients consenting for unilateral ALND (prior history of SLNBx allowed if <6 months from consent) OR patients consenting for unilateral SLNBx with possible ALND, with a clinically or radiographically positive lymph node OR a high likelihood of ALND per the Breast Surgeon
  • Identification of at least one transected lymphatic channel and at least one vein to be used for bypass at the time of ALND during surgery

排除标准

  • Male breast cancer patients
  • Non-English speaking participants
  • Female breast cancer patients with axillary recurrence
  • Female breast cancer patients who have a history of ALND
  • Female patients requiring bilateral ALND for the treatment of their breast cancer
  • Female breast patients treated with SLNBx only

结局指标

主要结局

the number of patients that had a decrease incidence of lymphedema

时间窗: up to 2 years

as measured by arm volume will be a ≥10% increase in arm volume

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (14)

Loading locations...

相似试验